Generics Global Industry Guide - Market Summary, Competitive Analysis and Forecast to 2025
Summary
Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The market value is evaluated at ex-factory prices.
- Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.
- Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.
- Note that any volumes of "1" (one) or 100% are due to rounding as MarketLine does not believe that generics will ever fully represent 100% of the medicinal market in any country or region.
- All market data and forecasts are represented in nominal terms (i.e., without adjustment for inflation) and all currency conversions used in the creation of this report have been calculated using constant 2020 annual average exchange rates.
- Forecast figures presented in this report are calculated using crisis scenarios for the market. The length of the pandemic and restrictions introduced by various countries are still difficult to predict. Many governments had introduced the national lockdowns and temporarily banned sales of products that are deemed "non-essential". As the length of the pandemic and its impact on this market is not certain, the data used in this report has been modeled taking forecast impacts on national economics into consideration.
- The global generics market had total revenues of $348.3bn in 2020, representing a compound annual growth rate (CAGR) of 5.1% between 2016 and 2020.
- Market consumption volume increased with a CAGR of 2.2% between 2016 and 2020, to reach a total of 68.0% in 2020.
- Historically, growth has been strongest in the Asia-Pacific and European regions and has been moderate in the US.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market
- Leading company profiles reveal details of key generics market players' global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the global generics market by value in 2020?
- What will be the size of the global generics market in 2025?
- What factors are affecting the strength of competition in the global generics market?
- How has the market performed over the last five years?
- How large is the global generics market in relation to its regional counterparts?
Generics Global Industry Guide - Market Summary, Competitive Analysis and Forecast to 2025
Table of Contents
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Competitive Landscape
2 Introduction
2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions
3 Global Generics
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
3.6. Macroeconomic Indicators
4 Generics in Asia-Pacific
4.1. Market Overview
4.2. Market Data
4.3. Market Segmentation
4.4. Market outlook
4.5. Five forces analysis
5 Generics in Europe
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
5.6. Macroeconomic Indicators
6 Generics in France
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
6.6. Macroeconomic Indicators
7 Generics in Germany
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
7.6. Macroeconomic Indicators
8 Generics in Italy
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis
8.6. Macroeconomic Indicators
9 Generics in Japan
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
9.6. Macroeconomic Indicators
10 Generics in Australia
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis
10.6. Macroeconomic Indicators
11 Generics in Canada
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
11.6. Macroeconomic Indicators
12 Generics in China
12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis
12.6. Macroeconomic Indicators
13 Generics in The Netherlands
13.1. Market Overview
13.2. Market Data
13.3. Market Segmentation
13.4. Market outlook
13.5. Five forces analysis
13.6. Macroeconomic Indicators
14 Generics in Spain
14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis
14.6. Macroeconomic Indicators
15 Generics in The United Kingdom
15.1. Market Overview
15.2. Market Data
15.3. Market Segmentation
15.4. Market outlook
15.5. Five forces analysis
15.6. Macroeconomic Indicators
16 Generics in The United States
16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis
16.6. Macroeconomic Indicators
17 Company Profiles
17.1. Sun Pharmaceutical Industries Ltd
17.2. Les Laboratoires Servier
17.3. STADA Arzneimittel AG
17.4. Daiichi Sankyo Co Ltd
17.5. Sawai Pharmaceutical Co Ltd
17.6. Aspen Pharmacare Holdings Ltd
17.7. Lupin Ltd
17.8. Apotex, Inc.
17.9. China Grand Pharmaceutical and Healthcare Holdings Limited
17.10. Sanofi SA
17.11. Esteve Group
17.12. Viatris Inc.
17.13. Teva Pharmaceutical Industries Limited
17.14. Pfizer Inc.
18 Appendix
18.1. Methodology
18.2. About MarketLine
List of Tables
Table 1: Global generics market value: $ billion, 2016-20
Table 2: Global generics market volume: %, 2016-20
Table 3: Global generics market geography segmentation: $ billion, 2020
Table 4: Global generics market value forecast: $ billion, 2020-25
Table 5: Global generics market volume forecast: %, 2020-25
Table 6: Global size of population (million), 2016-20
Table 7: Global gdp (constant 2005 prices, $ billion), 2016-20
Table 8: Global gdp (current prices, $ billion), 2016-20
Table 9: Global inflation, 2016-20
Table 10: Global consumer price index (absolute), 2016-20
Table 11: Global exchange rate, 2016-20
Table 12: Asia-Pacific generics market value: $ billion, 2016-20
Table 13: Asia-Pacific generics market volume: %, 2016-20
Table 14: Asia-Pacific generics market geography segmentation: $ billion, 2020
Table 15: Asia-Pacific generics market value forecast: $ billion, 2020-25
Table 16: Asia-Pacific generics market volume forecast: %, 2020-25
Table 17: Europe generics market value: $ billion, 2016-20
Table 18: Europe generics market volume: %, 2016-20
Table 19: Europe generics market geography segmentation: $ billion, 2020
Table 20: Europe generics market value forecast: $ billion, 2020-25
Table 21: Europe generics market volume forecast: %, 2020-25
Table 22: Europe size of population (million), 2016-20
Table 23: Europe gdp (constant 2005 prices, $ billion), 2016-20
Table 24: Europe gdp (current prices, $ billion), 2016-20
Table 25: Europe inflation, 2016-20
Table 26: Europe consumer price index (absolute), 2016-20
Table 27: Europe exchange rate, 2016-20
Table 28: France generics market value: $ million, 2016-20
Table 29: France generics market volume: %, 2016-20
Table 30: France generics market geography segmentation: $ million, 2020
Table 31: France generics market value forecast: $ million, 2020-25
Table 32: France generics market volume forecast: %, 2020-25
Table 33: France size of population (million), 2016-20
Table 34: France gdp (constant 2005 prices, $ billion), 2016-20
Table 35: France gdp (current prices, $ billion), 2016-20
Table 36: France inflation, 2016-20
Table 37: France consumer price index (absolute), 2016-20
Table 38: France exchange rate, 2016-20
Table 39: Germany generics market value: $ billion, 2016-20
Table 40: Germany generics market volume: %, 2016-20
Table 41: Germany generics market geography segmentation: $ billion, 2020
Table 42: Germany generics market value forecast: $ billion, 2020-25
Table 43: Germany generics market volume forecast: %, 2020-25
Table 44: Germany size of population (million), 2016-20
Table 45: Germany gdp (constant 2005 prices, $ billion), 2016-20
Table 46: Germany gdp (current prices, $ billion), 2016-20
Table 47: Germany inflation, 2016-20
Table 48: Germany consumer price index (absolute), 2016-20
Table 49: Germany exchange rate, 2016-20
Table 50: Italy generics market value: $ million, 2016-20
Table 51: Italy generics market volume: %, 2016-20
Table 52: Italy generics market geography segmentation: $ million, 2020
Table 53: Italy generics market value forecast: $ million, 2020-25
Table 54: Italy generics market volume forecast: %, 2020-25
Table 55: Italy size of population (million), 2016-20
Table 56: Italy gdp (constant 2005 prices, $ billion), 2016-20
Table 57: Italy gdp (current prices, $ billion), 2016-20
Table 58: Italy inflation, 2016-20
Table 59: Italy consumer price index (absolute), 2016-20
Table 60: Italy exchange rate, 2016-20
Table 61: Japan generics market value: $ billion, 2016-20
Table 62: Japan generics market volume: %, 2016-20
Table 63: Japan generics market geography segmentation: $ billion, 2020
Table 64: Japan generics market value forecast: $ billion, 2020-25
Table 65: Japan generics market volume forecast: %, 2020-25
List of Figures
Figure 1: Global generics market value: $ billion, 2016-20
Figure 2: Global generics market volume: %, 2016-20
Figure 3: Global generics market geography segmentation: % share, by value, 2020
Figure 4: Global generics market value forecast: $ billion, 2020-25
Figure 5: Global generics market volume forecast: %, 2020-25
Figure 6: Forces driving competition in the global generics market, 2020
Figure 7: Drivers of buyer power in the global generics market, 2020
Figure 8: Drivers of supplier power in the global generics market, 2020
Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2020
Figure 10: Factors influencing the threat of substitutes in the global generics market, 2020
Figure 11: Drivers of degree of rivalry in the global generics market, 2020
Figure 12: Asia-Pacific generics market value: $ billion, 2016-20
Figure 13: Asia-Pacific generics market volume: %, 2016-20
Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2020
Figure 15: Asia-Pacific generics market value forecast: $ billion, 2020-25
Figure 16: Asia-Pacific generics market volume forecast: %, 2020-25
Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2020
Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2020
Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2020
Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2020
Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2020
Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2020
Figure 23: Europe generics market value: $ billion, 2016-20
Figure 24: Europe generics market volume: %, 2016-20
Figure 25: Europe generics market geography segmentation: % share, by value, 2020
Figure 26: Europe generics market value forecast: $ billion, 2020-25
Figure 27: Europe generics market volume forecast: %, 2020-25
Figure 28: Forces driving competition in the generics market in Europe, 2020
Figure 29: Drivers of buyer power in the generics market in Europe, 2020
Figure 30: Drivers of supplier power in the generics market in Europe, 2020
Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2020
Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2020
Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2020
Figure 34: France generics market value: $ million, 2016-20
Figure 35: France generics market volume: %, 2016-20
Figure 36: France generics market geography segmentation: % share, by value, 2020
Figure 37: France generics market value forecast: $ million, 2020-25
Figure 38: France generics market volume forecast: %, 2020-25
Figure 39: Forces driving competition in the generics market in France, 2020
Figure 40: Drivers of buyer power in the generics market in France, 2020
Figure 41: Drivers of supplier power in the generics market in France, 2020
Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2020
Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2020
Figure 44: Drivers of degree of rivalry in the generics market in France, 2020
Figure 45: Germany generics market value: $ billion, 2016-20
Figure 46: Germany generics market volume: %, 2016-20
Figure 47: Germany generics market geography segmentation: % share, by value, 2020
Figure 48: Germany generics market value forecast: $ billion, 2020-25
Figure 49: Germany generics market volume forecast: %, 2020-25
Figure 50: Forces driving competition in the generics market in Germany, 2020
Figure 51: Drivers of buyer power in the generics market in Germany, 2020
Figure 52: Drivers of supplier power in the generics market in Germany, 2020
Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2020
Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2020
Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2020
Figure 56: Italy generics market value: $ million, 2016-20
Figure 57: Italy generics market volume: %, 2016-20
Figure 58: Italy generics market geography segmentation: % share, by value, 2020
Figure 59: Italy generics market value forecast: $ million, 2020-25
Figure 60: Italy generics market volume forecast: %, 2020-25
Figure 61: Forces driving competition in the generics market in Italy, 2020
Figure 62: Drivers of buyer power in the generics market in Italy, 2020
Figure 63: Drivers of supplier power in the generics market in Italy, 2020
Figure 64: Factors influencing the likelihood of new entrants in the generics market in Italy, 2020
Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 87
The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
Global Esomeprazole Magnesium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 74
The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030.
North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
Global Combination Therapy Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
Global Axitinib Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 68
The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
Global Lyme Disease Vaccine Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 70
The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi.
The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at......
Global Transdermal Absorption Patch Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
Global Ketoprofen Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis
The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
Global Methyl Salicylate Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 82
The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
Global Diclofenac Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
